Ekaterina V Bondarenko
Overview
Explore the profile of Ekaterina V Bondarenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Buzdin A, Heydarov R, Golounina O, Suntsova M, Matrosova A, Bondarenko E, et al.
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002253
Endogenous Cushing's syndrome (CS) is a rare neuroendocrine disorder characterized by either secondary cortisol increases due to an adrenocorticotropic hormone (ACTH)-secreting pituitary tumor (Cushing's disease (CD)), an ACTH-secreting neuroendocrine tumor...
2.
Eremkina A, Pylina S, Elfimova A, Gorbacheva A, Humbert L, Picazo M, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518523
The rarity and variability of MEN1-related primary hyperparathyroidism (mPHPT) has led to contradictory data regarding the bone phenotype in this patient population. A single-center retrospective study was conducted among young...
3.
Kamyshnikova L, Efremova O, Bondarenko E, Obolonkova N, Bolkhovitina O, Yusuf M
Wiad Lek
. 2021 Apr;
74(3 cz 1):465-470.
PMID: 33813451
Objective: The aim: To evaluate the structural and functional parameters of the cardiovascular system during atrial fibrillation (AF) in patients after a stroke. Patients And Methods: Materials and methods: In...
4.
Vyunova T, Andreeva L, Shevchenko K, Grigoriev V, Palyulin V, Lavrov M, et al.
Curr Mol Pharmacol
. 2020 Mar;
13(3):216-223.
PMID: 32124706
Background: Currently, the most dynamic areas in the glutamate receptor system neurobiology are the identification and development of positive allosteric modulators (PAMs) of glutamate ionotropic receptors. PAM-based drugs are of...